Handelsbanken Fonder Ab Emergent Bio Solutions Inc. Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding EBS
# of Institutions
174Shares Held
36.8MCall Options Held
336KPut Options Held
203K-
Black Rock Inc. New York, NY3.84MShares$22 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$18.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$12.2 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$11.2 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$8.81 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $285M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...